Jpmorgan Chase & Co »

Qualigen Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Qualigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Qualigen Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qualigen Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $211 386 0.55
2023-09-30 $390 387 1.01
2023-06-30 $351 385 0.91